Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Agathe Vély, Marie-Anne Couturier, Pascal Delepine, Ronan Le Calloch, Marjan Ertault, Thomas Gastinne, Chloé Plichon, Anne Lebreton, Marie-Antoinette Lester, Gaelle Larhantec, Nicolas Cormier, Sophie Fouquet, Roch Houot, Aline Tanguy-Schmidt, Mathilde Hunault-Berger & Corentin Orvain. (2023) Comparison of efficacy and toxicity according to etoposide and cytarabine dosing in BEAM conditioning followed by autologous stem cell transplantation in Hodgkin lymphoma. Leukemia & Lymphoma 0:0, pages 1-10.
Read now
Read now
Khalil Saleh, Alina Danu, Serge Koscielny, Clémence Legoupil, Sylvain Pilorge, Cristina Castilla-Llorente, David Ghez, Julien Lazarovici, Jean-Marie Michot, Nadine Khalife-Saleh, Valerie Lapierre, Kamelia Alenxandrova, Julia Arfi-Rouche, Jean-Henri Bourhis & Vincent Ribrag. (2018) A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience. Leukemia & Lymphoma 59:11, pages 2580-2587.
Read now
Read now
Alessandro Isidori, Anna Christofides & Giuseppe Visani. (2016) Novel regimens prior to autologous stem cell transplantation for the management of adults with relapsed/refractory non-Hodgkin lymphoma and Hodgkin lymphoma: alternatives to BEAM conditioning. Leukemia & Lymphoma 57:11, pages 2499-2509.
Read now
Read now
Eva-Susanne Strobel, Kris Bauchmüller, Gabriele Ihorst & Monika Engelhardt. (2007) Frequency, severity and risk factors for oral mucositis after BEAM conditioning and autologous peripheral blood stem cell transplantation: A single center analysis and review of the literature. Leukemia & Lymphoma 48:11, pages 2255-2260.
Read now
Read now
Articles from other publishers (20)
Agathe Vely, Jérôme Paillassa, Christopher Nunes Gomes, Aurélien Giltat, Sophie Fouquet, Anne Lebreton, Marion Klemencie, Aline Clavert, Aline Tanguy-Schmidt, Mathilde Hunault-Berger & Corentin Orvain. (2023) Toxicity Profile According to Etoposide and Cytarabine Dosing in Patients with Lymphoma Receiving Autologous Stem Cell Transplantation Following BEAM Conditioning. Annals of Hematology 102:8, pages 2225-2231.
Crossref
Crossref
Favre Simon, Sauvezie Mathieu, Vigouroux Stephane, Tabrizi Reza, Dilhuydy Marie-Sarah, Laboure Gaelle, Robles Margot, Milpied Noel & Bouabdallah Kamal. (2021) High incidence rate of human herpesvirus 6 infection after Bendamustine, Cytarabine, Etoposide and Melphalan conditioning regimen: A monocentric and retrospective study. Archives of Clinical Nephrology, pages 038-043.
Crossref
Crossref
Do Young Kim, Joo-seop Chung, Jae-Cheol Jo, Su-Hee Cho & Ho-Jin Shin. (2020) Phase II study of safety and efficacy of BEB (bendamustine, etoposide, and busulfan) conditioning regimen for autologous stem cell transplantation in non-Hodgkin lymphoma. Annals of Hematology 99:4, pages 819-828.
Crossref
Crossref
Benjamin A. Derman, Keriann KordasJean RidgewaySelina ChowWilliam DaleSang Mee Lee, Elingel AguadaAndrzej J. JakubowiakJagoda JasielecJustin KlineSatyajit KosuriRichard A. Larson, Hongtao Liu, Mylove MortelOlatoyosi OdenikeJennifer Pisano, Peter RiedellWendy StockMichael R. BishopAndrew S. Artz. (2019) Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults. Blood Advances 3:22, pages 3488-3498.
Crossref
Crossref
Karin Hohloch, Samira Zeynalova, Björn Chapuy, Michael Pfreundschuh, Markus Loeffler, Marita Ziepert, Alfred C. Feller, Lorenz Trümper, Dirk Hasenclever, Gerald Wulf & Norbert Schmitz. (2016) Modified BEAM with triple autologous stem cell transplantation for patients with relapsed aggressive non-Hodgkin lymphoma. Annals of Hematology 95:7, pages 1121-1128.
Crossref
Crossref
Gordon L. PhillipsIIII, Steven H. Bernstein, Jane L. Liesveld, Camille N. Abboud, Michael W. Becker, Louis S. Constine, J.J. Ifthikharuddin, John E. Loughner, Laurie A. Milner, David H. Vesole & Jonathan W. Friedberg. (2011) A Phase I Trial: Dose Escalation of Melphalan in the “BEAM” Regimen Using Amifostine Cytoprotection. Biology of Blood and Marrow Transplantation 17:7, pages 1033-1042.
Crossref
Crossref
Helen V Worthington, Janet E Clarkson, Gemma Bryan, Susan Furness, Anne-Marie Glenny, Anne Littlewood, Martin G McCabe, Stefan Meyer, Tasneem Khalid & Philip Riley. (2011) Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews 2021:3.
Crossref
Crossref
Helen V Worthington, Jan E Clarkson, Gemma Bryan, Susan Furness, Anne-Marie Glenny, Anne Littlewood, Martin G McCabe, Stefan Meyer & Tasneem Khalid. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Helen V Worthington, Jan E Clarkson & Tim OB Eden. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
H. Miles Prince, Geoff Regester, Priscilla Gates, Lina Jablonskis, John F. Seymour, Kate Lillie, Raelene West, Max Wolf, Henry Januszewicz & David Belford. (2005) A Phase Ib Clinical Trial of PV701, a Milk-Derived Protein Extract, for the Prevention and Treatment of Oral Mucositis in Patients Undergoing High-Dose BEAM Chemotherapy. Biology of Blood and Marrow Transplantation 11:7, pages 512-520.
Crossref
Crossref
G.L. PhillipsIIII, C.N. Abboud, S.H. Bernstein, J.W. Friedberg, J.J. Ifthikharuddin, J.E. Lancet, J.L. Liesveld, E. Spreng, V. Johnson, M. Chapman & D.H. Vesole. (2004) Phase I study for poor-prognosis lymphoma: Augmentation of the “BEAM” regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation — a preliminary report. Seminars in Oncology 31, pages 59-61.
Crossref
Crossref
A Martín, M D Caballero, J A Pérez-Simón, N López-Holgado, M V Mateos, M C Cañizo & J F San Miguel. (2004) Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study. Bone Marrow Transplantation 34:8, pages 675-682.
Crossref
Crossref
Stephen T. Sonis, Linda S. Elting, Dorothy Keefe, Douglas E. Peterson, Mark Schubert, Martin Hauer-Jensen, B. Nebiyou Bekele, Judith Raber-Durlacher, J. Peter Donnelly & Edward B. Rubenstein. (2004) Perspectives on cancer therapy-induced mucosal injury. Cancer 100:S9, pages 1995-2025.
Crossref
Crossref
A Martín, J-A Pérez-Simón, M D Caballero, N López, R García-Sanz, L Vázquez, M C del Cañizo & J F San Miguel. (2004) Effect of cumulative etoposide doses on the outcome of autologous peripheral-blood progenitor-cell transplantation for lymphoma. Bone Marrow Transplantation 33:6, pages 579-587.
Crossref
Crossref
J. Hansz, J. Gozdzik & D. Drozdowska. 2000. Transplantation in Hematology and Oncology. Transplantation in Hematology and Oncology
252
257
.
David C. Linch & Anthony H. Goldstone. (2001) High‐dose therapy for Hodgkin's disease. British Journal of Haematology 107:4, pages 685-690.
Crossref
Crossref
C N Harrison, W Gregory, G Vaughan Hudson, S Devereux, A H Goldstone, B Hancock, D Winfield, A K MacMillan, P Hoskin, A C Newland, D Milligan & D C Linch. (1999) High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin’s disease is unlikely to be associated with a major increased risk of secondary MDS/AML. British Journal of Cancer 81:3, pages 476-483.
Crossref
Crossref
A. R. Perry, A. J. Peniket, M. J. Watts, D. Leverett, A. H. Goldstone & D. C. Linch. (2005) Peripheral blood stem cell versus autologous bone marrow transplantation for Hodgkin's disease: equivalent survival outcome in a single‐centre matched‐pair analysis. British Journal of Haematology 105:1, pages 280-287.
Crossref
Crossref
Ronald Bukowski. (1999) Cytoprotection in the treatment of pediatric cancer: Review of current strategies in adults and their application to children. Medical and Pediatric Oncology 32:2, pages 124-134.
Crossref
Crossref
N. Mounier & C. Gisselbrecht. (1998) Conditioning regimens before transplantation in patients with aggressive non-Hodgkin’s lymphoma. Annals of Oncology 9, pages S15-S21.
Crossref
Crossref